H Mellstedt

1.0k total citations
36 papers, 874 citations indexed

About

H Mellstedt is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, H Mellstedt has authored 36 papers receiving a total of 874 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 15 papers in Radiology, Nuclear Medicine and Imaging and 14 papers in Molecular Biology. Recurrent topics in H Mellstedt's work include Monoclonal and Polyclonal Antibodies Research (14 papers), Lymphoma Diagnosis and Treatment (9 papers) and Glycosylation and Glycoproteins Research (8 papers). H Mellstedt is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (14 papers), Lymphoma Diagnosis and Treatment (9 papers) and Glycosylation and Glycoproteins Research (8 papers). H Mellstedt collaborates with scholars based in Sweden, United Kingdom and Italy. H Mellstedt's co-authors include G. Holm, Sten Hammarström, D Pettersson, Hans Wigzell, Magnus Björkholm, Bo Johansson, Kenneth Nilsson, E Hedfors, B. Bloth and Bertil Axelsson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Annals of Oncology.

In The Last Decade

H Mellstedt

35 papers receiving 726 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H Mellstedt Sweden 17 432 297 271 206 193 36 874
C. R. Barker United Kingdom 19 506 1.2× 236 0.8× 318 1.2× 142 0.7× 378 2.0× 39 1.1k
D Pettersson Sweden 17 390 0.9× 263 0.9× 185 0.7× 326 1.6× 284 1.5× 24 806
TJ Hamblin United Kingdom 14 472 1.1× 307 1.0× 283 1.0× 364 1.8× 426 2.2× 25 1.0k
J L Preud'homme France 16 275 0.6× 159 0.5× 237 0.9× 115 0.6× 131 0.7× 39 700
C. P. Worman United Kingdom 19 830 1.9× 235 0.8× 216 0.8× 183 0.9× 611 3.2× 61 1.2k
Sigrid Klein Germany 16 333 0.8× 211 0.7× 224 0.8× 137 0.7× 55 0.3× 21 717
LE Silberstein United States 9 226 0.5× 217 0.7× 82 0.3× 264 1.3× 143 0.7× 12 610
Lorna Mackenzie United Kingdom 17 668 1.5× 397 1.3× 215 0.8× 66 0.3× 202 1.0× 33 916
B Dörken Germany 8 260 0.6× 116 0.4× 126 0.5× 293 1.4× 136 0.7× 12 603
U. Winkler Germany 10 364 0.8× 205 0.7× 106 0.4× 75 0.4× 269 1.4× 12 785

Countries citing papers authored by H Mellstedt

Since Specialization
Citations

This map shows the geographic impact of H Mellstedt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Mellstedt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Mellstedt more than expected).

Fields of papers citing papers by H Mellstedt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Mellstedt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Mellstedt. The network helps show where H Mellstedt may publish in the future.

Co-authorship network of co-authors of H Mellstedt

This figure shows the co-authorship network connecting the top 25 collaborators of H Mellstedt. A scholar is included among the top collaborators of H Mellstedt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Mellstedt. H Mellstedt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Palma, Marzia, A Choudhury, & H Mellstedt. (2009). Cancer vaccines for non-small-cell lung cancer.. PubMed. 64(6). 643–53. 1 indexed citations
2.
Mellstedt, H. (2007). Clinical signs and symptoms at diagnosis and its differential diagnosis. Annals of Oncology. 18. i14–i21. 3 indexed citations
3.
Österborg, Anders, et al.. (1996). Immunoglobulins in multiple myeloma. 36. 1 indexed citations
4.
Fagerberg, Jan, et al.. (1995). Human anti-idiotypic antibodies induced a humoral and cellular immune response against a colorectal carcinoma-associated antigen in patients.. Proceedings of the National Academy of Sciences. 92(11). 4773–4777. 62 indexed citations
5.
Reali, Eva, H Mellstedt, & Giuseppe Masucci. (1993). GM-CSF augments the IL-4-induced cytotoxic activity of human mononuclear cells in the presence of the mouse monoclonal antibody 17-1A. 6(3). 116–122. 1 indexed citations
7.
Tani, Edneia, Jan Liliemark, Erik Svedmyr, et al.. (1989). Cytomorphology and immunocytochemistry of fine needle aspirates from blastic non-Hodgkin's lymphomas.. PubMed. 33(3). 363–71. 28 indexed citations
8.
Steinitz, Michael, et al.. (1988). Human monoclonal anti-idiotypic antibodies. I. Establishment of immortalized cell lines from a tumor patient treated with mouse monoclonal antibodies.. The Journal of Immunology. 141(10). 3516–3522. 35 indexed citations
9.
Lindemalm, C., H Mellstedt, Bo Nilsson, et al.. (1987). Blood clonal B cell excess (CBE) at diagnosis in patients with non-Hodgkin lymphoma (NHL). Relation to clinical stage, histopathology and response to treatment. European Journal of Cancer and Clinical Oncology. 23(6). 749–753. 8 indexed citations
10.
Herlyn, Dorothee, Henry F. Sears, Dimitrios Iliopoulos, et al.. (1986). Anti-idiotypic antibodies to monoclonal antibody CO17-1A.. PubMed. 5 Suppl 1(34). 21–8. 33 indexed citations
11.
Holm, G., Magnus Björkholm, Bo Johansson, H Mellstedt, & C. Lindemalm. (1982). Monocyte function in Hodgkin's disease.. PubMed. 47(1). 162–8. 16 indexed citations
12.
Holm, G., Magnus Björkholm, H Mellstedt, & Petra Nilsson. (1982). Suppression of monocyte dependent lymphocyte stimulation by sera from patients with Hodgkin's disease.. PubMed. 7(1). 51–4. 1 indexed citations
13.
Hammarström, Lennart, Smith Rjh, D Pettersson, H Mellstedt, & G. Holm. (1981). Functional studies on B cells in human bone marrow: in vitro mitogen stimulation of normal and malignant B cells.. PubMed. 43(1). 157–64. 11 indexed citations
14.
Holm, G., et al.. (1980). Antibody-dependent haemolytic activity of human leukaemic cells.. PubMed. 42(1). 121–6. 7 indexed citations
15.
Hellström, Ulla, H Mellstedt, Peter Perlmann, G. Holm, & D Pettersson. (1976). Receptors for Helix pomatia A haemagglutinin on leukaemic lymphocytes from patients with chronic lymphocytic leukaemia (CLL).. PubMed. 26(2). 196–203. 47 indexed citations
16.
Johansson, Bo, D. Killander, G. Holm, et al.. (1975). Epstein-Barr virus (EBV)-associated antibody patterns in relation to the deficiency of cell-mediated immunity in patients with Hodgkin's disease.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 237–47. 21 indexed citations
17.
Holm, G., D Pettersson, H Mellstedt, E Hedfors, & B. Bloth. (1975). Lymphocyte subpopulations in peripheral blood of healthy persons. Characterization by surface markers and lack of selection during purification. Clinical & Experimental Immunology. 20(3). 443. 69 indexed citations
18.
Mellstedt, H. (1975). In vitro activation of human T and B lymphocytes by pokeweed mitogen.. PubMed. 19(1). 75–82. 54 indexed citations
19.
Mellstedt, H & D Pettersson. (1974). Lymphocyte Subpopulations in Chronic Lymphocytic Leukemia. Scandinavian Journal of Immunology. 3(3). 303–310. 23 indexed citations
20.
Mellstedt, H & G. Holm. (1973). In vitro studies of lymphocytes from patients with plasma cell myeloma. I. Stimulation by mitogens and cytotoxic activities.. PubMed. 15(3). 309–20. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026